CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-10 | Duato Joaquin CEO and Chairman of the Board | Grant or award · Performance Share Units | +19,282 | 19,282 | ||
| 2025-02-10 | Broadhurst Vanessa EVP, Global Corp Affairs | Grant or award · Performance Share Units | +2,910 | 2,910 | ||
| 2025-02-07 | Duato Joaquin CEO and Chairman of the Board | Option exercise | +126,369 | $100.06 | $12.6M | 489,671 |
| 2025-02-07 | Duato Joaquin CEO and Chairman of the Board | Shares withheld for taxes | −100,643 | $153.12 | $15.4M | 389,028 |
| 2025-02-07 | Duato Joaquin CEO and Chairman of the Board | Option exercise · Employee Stock Options (Right to Buy) | −126,369 | $100.06 | $12.6M | 0 |
| 2025-02-07 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise | +32,762 | $100.06 | $3.3M | 115,027.87 |
| 2025-02-07 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Shares withheld for taxes | −26,076 | $153.12 | $4.0M | 88,951.87 |
| 2025-02-07 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise · Employee Stock Options (Right to Buy) | −32,762 | $100.06 | $3.3M | 0 |
| 2025-02-07 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise | +58,504 | $100.06 | $5.9M | 213,355 |
| 2025-02-07 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Shares withheld for taxes | −47,436 | $153.12 | $7.3M | 165,919 |
| 2025-02-07 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise · Employee Stock Options (Right to Buy) | −58,504 | $100.06 | $5.9M | 0 |
| 2025-02-07 | Wolk Joseph J Exec VP, CFO | Option exercise | +13,015 | $100.06 | $1.3M | 13,015 |
| 2025-02-07 | Wolk Joseph J Exec VP, CFO | Sale | −13,015 | $153.89 | $2.0M | 0 |
| 2025-02-07 | Wolk Joseph J Exec VP, CFO | Option exercise · Employee Stock Options (Right to Buy) | −13,015 | $100.06 | $1.3M | 0 |
| 2024-12-12 | WEINBERGER MARK A Director | Purchase | +1,000 | $147.22 | $147K | 1,000 |
| 2024-12-10 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +208.79 | $149.67 | $31K | 2,804.59 |
| 2024-12-10 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +334.52 | $149.67 | $50K | 11,380.22 |
| 2024-10-17 | Wolk Joseph J Exec VP, CFO | Gift | −68,835 | 0 | ||
| 2024-10-17 | Wolk Joseph J Exec VP, CFO | Gift | +68,835 | 68,835 | ||
| 2024-09-10 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +188.32 | $165.94 | $31K | 2,574.47 |
Page 24 of 33 · 658 trades